MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Chimera Investment Co. (NYSE:CIM - Free Report) by 9.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 777,228 shares of the real estate investment trust's stock after acquiring an additional 69,032 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned approximately 0.96% of Chimera Investment worth $10,881,000 as of its most recent SEC filing.
Other hedge funds have also bought and sold shares of the company. Graham Capital Management L.P. increased its position in Chimera Investment by 360.7% in the fourth quarter. Graham Capital Management L.P. now owns 75,790 shares of the real estate investment trust's stock worth $1,061,000 after buying an additional 59,340 shares during the last quarter. Deutsche Bank AG increased its position in Chimera Investment by 47.6% in the fourth quarter. Deutsche Bank AG now owns 69,741 shares of the real estate investment trust's stock worth $976,000 after buying an additional 22,476 shares during the last quarter. Bank of America Corp DE increased its position in Chimera Investment by 18.5% in the fourth quarter. Bank of America Corp DE now owns 115,959 shares of the real estate investment trust's stock worth $1,623,000 after buying an additional 18,075 shares during the last quarter. Gallagher Fiduciary Advisors LLC increased its position in Chimera Investment by 20.2% in the fourth quarter. Gallagher Fiduciary Advisors LLC now owns 19,810 shares of the real estate investment trust's stock worth $277,000 after buying an additional 3,323 shares during the last quarter. Finally, Northern Trust Corp increased its position in Chimera Investment by 9.6% in the fourth quarter. Northern Trust Corp now owns 800,838 shares of the real estate investment trust's stock worth $11,212,000 after buying an additional 70,362 shares during the last quarter. 48.44% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on CIM. UBS Group raised Chimera Investment from a "neutral" rating to a "buy" rating and raised their target price for the stock from $11.50 to $15.00 in a research report on Wednesday, May 14th. Royal Bank of Canada upgraded Chimera Investment to a "moderate buy" rating in a research report on Friday, March 14th. JMP Securities reiterated a "market perform" rating on shares of Chimera Investment in a research report on Thursday, January 23rd. Finally, Wall Street Zen upgraded Chimera Investment from a "hold" rating to a "buy" rating in a research report on Thursday, May 15th. Two equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $15.50.
Check Out Our Latest Stock Analysis on CIM
Insider Activity at Chimera Investment
In other Chimera Investment news, Director Gerard Creagh acquired 12,500 shares of the company's stock in a transaction that occurred on Tuesday, March 11th. The stock was bought at an average price of $13.31 per share, with a total value of $166,375.00. Following the completion of the purchase, the director now owns 138,127 shares of the company's stock, valued at approximately $1,838,470.37. This represents a 9.95% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.91% of the stock is owned by corporate insiders.
Chimera Investment Stock Performance
Shares of NYSE CIM traded down $0.24 during mid-day trading on Thursday, hitting $12.90. The company had a trading volume of 174,680 shares, compared to its average volume of 601,304. The company has a market capitalization of $1.04 billion, a price-to-earnings ratio of 11.93 and a beta of 1.76. Chimera Investment Co. has a 1 year low of $9.85 and a 1 year high of $16.89. The company has a current ratio of 0.06, a quick ratio of 3.03 and a debt-to-equity ratio of 2.82. The stock's 50-day moving average price is $12.38 and its 200-day moving average price is $13.72.
Chimera Investment (NYSE:CIM - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The real estate investment trust reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.03. The company had revenue of $69.22 million during the quarter, compared to analysts' expectations of $72.07 million. Chimera Investment had a return on equity of 7.00% and a net margin of 20.28%. On average, sell-side analysts forecast that Chimera Investment Co. will post 1.57 earnings per share for the current year.
Chimera Investment Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 30th. Investors of record on Monday, March 31st were paid a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a yield of 11.47%. The ex-dividend date was Monday, March 31st. Chimera Investment's dividend payout ratio is 98.67%.
About Chimera Investment
(
Free Report)
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.
Recommended Stories

Before you consider Chimera Investment, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chimera Investment wasn't on the list.
While Chimera Investment currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.